Overview

Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of the Biologic Lung Volume Reduction System (BLVR) for patients with advanced emphysema refractory to medical therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Aeris Therapeutics